Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MCKESSON CORPORATION

(MCK)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/17/2021 06/18/2021 06/21/2021 06/22/2021 06/23/2021 Date
189.4(c) 184.89(c) 188.72(c) 190.1(c) 188.83(c) Last
1 155 900 2 471 474 1 322 977 1 612 064 1 136 308 Volume
-1.06% -2.38% +2.07% +0.73% -0.67% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 249 B - -
Net income 2022 2 717 M - -
Net Debt 2022 539 M - -
P/E ratio 2022 10,9x
Yield 2022 0,93%
Sales 2023 258 B - -
Net income 2023 2 742 M - -
Net cash position 2023 1 279 M - -
P/E ratio 2023 10,4x
Yield 2023 0,96%
Capitalization 29 206 M 29 206 M -
EV / Sales 2022 0,12x
EV / Sales 2023 0,11x
Nbr of Employees 67 500
Free-Float 57,3%
More Financials
Company
McKesson Corporation is a healthcare supply chain management solution, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare. It operates through three segments: United States... 
Sector
Drug Retailers
Calendar
07/23 | 09:30amShareholder meeting
More about the company
Ratings of McKesson Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about MCKESSON CORPORATION
06/23GLOBAL MARKETS LIVE : Microsoft, Morgan Stanley, Heineken, Twitter, AstraZeneca...
06/22BRIDGEBIO PHARMA  : TRUSELTIQ FDA Approved for Treatment of Cholangiocarcinoma A..
AQ
06/21MCKESSON  : TRUSELTIQ (infigratinib), FDA Approved for Treatment of Cholangiocar..
PU
06/11MCKESSON  : LUMAKRAS (sotorasib), FDA Approved for Treatment of KRAS G12C-mutate..
PU
06/08MCKESSON  : 2021 Annual Meeting of Shareholders and Proxy Statement
PU
06/08MCKESSON  : 2021 Annual Report
PU
06/08Amazon Pharmacy offers half-yearly prescriptions starting at $6
RE
06/07CORRECTION : Mizuho Securities Maintains Price Target for McKesson at $205, Reit..
MT
06/07MCKESSON  : Mizuho Securities Adjusts McKesson PT to $190 From $205, Maintains N..
MT
06/03MCKESSON  : Insider Sale at McKesson (MCK) Continues Selling Trend
MT
06/03MCKESSON  : US Oncology Research, The US Oncology Network and Ontada Announce Cl..
PU
06/02INSIDER TRENDS : Insider at McKesson Converts/Exercises Derivative Security, Sel..
MT
06/02INSIDER TRENDS : Insider at McKesson Acquires Stock Via Option/Derivative Securi..
MT
06/02INSIDER TRENDS : 90-Day Insider Buying Trend Reduced with Disposition of McKesso..
MT
06/02INSIDER TRENDS : McKesson Insider Exercises Option/Derivative Security to Acquir..
MT
More news
News in other languages on MCKESSON CORPORATION
06/23PRESSE : US-Pharmahändler McKesson will sich vom Europa-Geschäft trennen
06/23STOCK MARKET PARIS : Happy Brexit to you
06/23EN DIRECT DES MARCHES  : Pernod Ricard, TotalEnergies, Abivax, Microsoft, Heinek..
04/29DGAP-HV : Brenntag SE: Bekanntmachung der -5-
2020La justice américaine accuse Walmart d'avoir alimenté la crise des opiacés
More news
Analyst Recommendations on MCKESSON CORPORATION
More recommendations
Chart MCKESSON CORPORATION
Duration : Period :
McKesson Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MCKESSON CORPORATION
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Last Close Price 188,83 $
Average target price 222,93 $
Spread / Average Target 18,1%
EPS Revisions
Managers and Directors
NameTitle
Brian Scott Tyler Chief Executive Officer & Director
Britt J. Vitalone Chief Financial Officer & Executive Vice President
Edward A. Mueller Independent Chairman
Nancy Flores Chief Technology & Information Officer, EVP
M. Christine Jacobs Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
MCKESSON CORPORATION8.57%29 206
WALGREENS BOOTS ALLIANCE, INC.30.59%45 018
JD HEALTH INTERNATIONAL INC.-29.60%43 306
CARDINAL HEALTH, INC.5.84%16 330
HUADONG MEDICINE CO., LTD72.63%12 392
SINOPHARM GROUP CO., LTD.24.34%9 424